All Stories

  1. Deep Brain Stimulation Selection Criteria for Parkinson’s Disease: Time to Go beyond CAPSIT-PD

    Article • Journal of Clinical Medicine, December 2020, MDPI AG

    Carlo Alberto Artusi

  2. COVID-19 in Parkinson's disease: Report on prevalence and outcome

    Article • Parkinsonism & Related Disorders, November 2020, Elsevier

    Carlo Alberto Artusi

  3. Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail

    Article • Neurological Sciences, October 2020, Springer Science + Business Media

    Carlo Alberto Artusi

  4. Levodopa/Carbidopa Intestinal Gel Long‐Term Outcome in Parkinson's Disease: Focus on Dyskinesia

    Article • Movement Disorders Clinical Practice, September 2020, Wiley

    Carlo Alberto Artusi, paola berchialla

  5. Neurological comorbidity and severity of COVID-19

    Article • Journal of Neurology, August 2020, Springer Science + Business Media

    Carlo Alberto Artusi

  6. Implementation of Mobile Health Technologies in Clinical Trials of Movement Disorders: Underutilized Potential

    Article • Neurotherapeutics, July 2020, Springer Science + Business Media

    Carlo Alberto Artusi

  7. Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications

    Article • Journal of Neurology, June 2020, Springer Science + Business Media

    Carlo Alberto Artusi

  8. Smartphone-Based Evaluation of Postural Stability in Parkinson’s Disease

    Article • Electronics, June 2020, MDPI AG

    Carlo Alberto Artusi, Luigi Borzì

  9. Tuning Deep Brain Stimulation related depression by frequency modulation: a case report

    Article • Brain Stimulation, June 2020, Elsevier

    Carlo Alberto Artusi

  10. Should We Consider Deep Brain Stimulation Discontinuation in Late‐Stage Parkinson's Disease?

    Article • Movement Disorders, May 2020, Wiley

    Carlo Alberto Artusi, paola berchialla

  11. Changing the Side of Pisa Syndrome: A Case of Over‐Recovery with Botulinum Toxin

    Article • Movement Disorders Clinical Practice, April 2020, Wiley

    Carlo Alberto Artusi

  12. Does the Degree of Trunk Bending Predict Patient Disability, Motor Impairment, Falls, and Back Pain in Parkinson's Disease?

    Article • Frontiers in Neurology, March 2020, Frontiers

    Carlo Alberto Artusi

  13. Video analysis of long-term effects of levodopa-carbidopa intestinal gel on gait and posture in advanced Parkinson’s disease

    Article • Neurological Sciences, March 2020, Springer Science + Business Media

    Carlo Alberto Artusi

  14. Differential response to pallidal deep brain stimulation among monogenic dystonias: systematic review and meta-analysis

    Article • Journal of Neurology Neurosurgery & Psychiatry, February 2020, BMJ

    Carlo Alberto Artusi

  15. Smartphone-Based Estimation of Leg Agility in People With Parkinson's Disease

    Article • IEEE Open Journal of Engineering in Medicine and Biology, January 2020, Institute of Electrical & Electronics Engineers (IEEE)

    Carlo Alberto Artusi, Luigi Borzì

  16. Validity of the wall goniometer as a screening tool to detect postural abnormalities in Parkinson's disease

    Article • Parkinsonism & Related Disorders, December 2019, Elsevier

    Carlo Alberto Artusi

  17. Beyond 10 years of levodopa intestinal infusion experience: Analysis of mortality and its predictors

    Article • Parkinsonism & Related Disorders, October 2019, Elsevier

    Carlo Alberto Artusi

  18. Postural Abnormalities in Parkinson's Disease: An Epidemiological and Clinical Multicenter Study

    Article • Movement Disorders Clinical Practice, July 2019, Wiley

    Dr Christian Geroin, Carlo Alberto Artusi

  19. Home monitoring of motor fluctuations in Parkinson’s disease patients

    Article • Journal of Reliable Intelligent Environments, July 2019, Springer Science + Business Media

    Carlo Alberto Artusi, Luigi Borzì

  20. Telemedicine in Neurological Disorders: Opportunities and Challenges

    Article • Telemedicine and e-Health, July 2019, Mary Ann Liebert Inc

    Carlo Alberto Artusi

  21. Complex therapies for advanced Parkinson’s disease: what is the role of doctor-patient communication?

    Article • Neurological Sciences, June 2019, Springer Science + Business Media

    Carlo Alberto Artusi

  22. Levodopa-Induced Dyskinesias and Dyskinesias-Reduced-Self-Awareness in Parkinson’s Disease: A Neurocognitive Approach

    Article • June 2019, IntechOpen

    Carlo Alberto Artusi

  23. Pisa Syndrome in Parkinson's Disease Is Associated With Specific Cognitive Alterations

    Article • Frontiers in Neurology, May 2019, Frontiers

    Carlo Alberto Artusi

  24. Long‐term effect of levodopa‐carbidopa intestinal gel on axial signs in Parkinson’s disease

    Article • Acta Neurologica Scandinavica, May 2019, Wiley

    Carlo Alberto Artusi

  25. Botulinum toxin for Pisa syndrome: An MRI-, ultrasound- and electromyography-guided pilot study

    Article • Parkinsonism & Related Disorders, May 2019, Elsevier

    Carlo Alberto Artusi

  26. Effect of subthalamic deep brain stimulation on posture in Parkinson's disease: A blind computerized analysis

    Article • Parkinsonism & Related Disorders, May 2019, Elsevier

    Carlo Alberto Artusi

  27. Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study

    Article • Journal of Neurology, April 2019, Springer Science + Business Media

    Carlo Alberto Artusi

  28. Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease

    Article • JAMA Network Open, February 2019, American Medical Association (AMA)

    Carlo Alberto Artusi

  29. Levodopa‐Induced Neuropathy: A Systematic Review

    Article • Movement Disorders Clinical Practice, November 2018, Wiley

    Carlo Alberto Artusi

  30. Early diagnosis of progressive multifocal leucoencephalopathy: longitudinal lesion evolution

    Article • Journal of Neurology Neurosurgery & Psychiatry, November 2018, BMJ

    Carlo Alberto Artusi

  31. Cardiovascular autonomic neuropathy and falls in Parkinson disease: a prospective cohort study

    Article • Journal of Neurology, October 2018, Springer Science + Business Media

    Carlo Alberto Artusi

  32. Dopaminergic dose adjustment and negative affective symptoms after deep brain stimulation

    Article • Journal of the Neurological Sciences, July 2018, Elsevier

    Carlo Alberto Artusi

  33. Subthalamic deep brain stimulation and levodopa in Parkinson’s disease: a meta-analysis of combined effects

    Article • Journal of Neurology, June 2018, Springer Science + Business Media

    Carlo Alberto Artusi

  34. Deep brain stimulation in uncommon tremor disorders: indications, targets, and programming

    Article • Journal of Neurology, March 2018, Springer Science + Business Media

    Carlo Alberto Artusi

  35. Effects of intestinal Levodopa infusion on freezing of gait in Parkinson disease

    Article • Journal of the Neurological Sciences, February 2018, Elsevier

    Carlo Alberto Artusi

  36. Orthostatic hypotension in Parkinson disease: Impact on health care utilization

    Article • Parkinsonism & Related Disorders, February 2018, Elsevier

    Carlo Alberto Artusi

  37. Integration of technology-based outcome measures in clinical trials of Parkinson and other neurodegenerative diseases

    Article • Parkinsonism & Related Disorders, January 2018, Elsevier

    Carlo Alberto Artusi

  38. Subthalamic deep brain stimulation and trunk posture in Parkinson's disease

    Article • Acta Neurologica Scandinavica, December 2017, Wiley

    Maurizio Zibetti, Carlo Alberto Artusi

  39. To do or not to do? plasma exchange and timing of steroid administration in progressive multifocal leukoencephalopathy

    Article • Annals of Neurology, October 2017, Wiley

    Carlo Alberto Artusi

  40. Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis

    Article • Expert Opinion on Drug Safety, July 2017, Taylor & Francis

    Carlo Alberto Artusi

  41. Natalizumab in Multiple Sclerosis: Long-Term Management

    Article • International Journal of Molecular Sciences, April 2017, MDPI AG

    Carlo Alberto Artusi

  42. Prevalence and burden of dysautonomia in advanced Parkinson's disease

    Article • Movement Disorders, March 2017, Wiley

    Prof. Cristoforo Comi, Carlo Alberto Artusi

  43. Active CMV infection in two patients with multiple sclerosis treated with alemtuzumab

    Article • Multiple Sclerosis Journal, February 2017, SAGE Publications

    Carlo Alberto Artusi

  44. The still under-investigated role of cognitive deficits in PML diagnosis

    Article • Multiple Sclerosis and Demyelinating Disorders, January 2017, Springer Science + Business Media

    Carlo Alberto Artusi

  45. Natalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent Registry

    Article • PLoS ONE, December 2016, PLOS

    Carlo Alberto Artusi

  46. Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

    Article • Journal of Visualized Experiments, November 2016, MyJove Corporation

    Carlo Alberto Artusi

  47. Parkinsonism–hyperpyrexia syndrome and deep brain stimulation

    Article • Journal of Neurology, November 2015, Springer Science + Business Media

    Carlo Alberto Artusi

  48. Long-term follow-up of ultrasound-guided botulinum toxin-A injections for sialorrhea in neurological dysphagia

    Article • Journal of Neurology, September 2015, Springer Science + Business Media

    Carlo Alberto Artusi

  49. Earlier versus later subthalamic deep brain stimulation in Parkinson's disease

    Article • Parkinsonism & Related Disorders, August 2015, Elsevier

    Carlo Alberto Artusi

  50. Subthalamic deep brain stimulation: clinical and neuropsychological outcomes in mild cognitive impaired parkinsonian patients

    Article • Deutsche Zeitschrift für Nervenheilkunde, June 2014, Springer Science + Business Media

    Carlo Alberto Artusi

  51. Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience

    Article • European Journal of Neurology, December 2013, Wiley

    Maurizio Zibetti, Carlo Alberto Artusi

  52. Medical therapy and subthalamic deep brain stimulation in advanced Parkinson's disease: a different long-term outcome?

    Article • Journal of Neurology Neurosurgery & Psychiatry, July 2013, BMJ

    Carlo Alberto Artusi

  53. Prospective assessment of peripheral neuropathy in Duodopa-treated parkinsonian patients

    Article • Acta Neurologica Scandinavica, July 2013, Wiley

    Carlo Alberto Artusi

  54. 80 Hz versus 130 Hz subthalamic nucleus deep brain stimulation: Effects on involuntary movements

    Article • Parkinsonism & Related Disorders, April 2013, Elsevier

    Carlo Alberto Artusi

  55. Long-term duodenal levodopa infusion in Parkinson’s disease: a 3-year motor and cognitive follow-up study

    Article • Deutsche Zeitschrift für Nervenheilkunde, July 2012, Springer Science + Business Media

    Carlo Alberto Artusi

  56. Transient effects of 80 Hz stimulation on gait in STN DBS treated PD patients: A 15 months follow-up study

    Article • Brain Stimulation, July 2012, Elsevier

    Carlo Alberto Artusi

  57. Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: a role for age at disease onset?

    Article • Journal of Neurology Neurosurgery & Psychiatry, December 2011, BMJ

    Carlo Alberto Artusi

  58. Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease

    Article • Movement Disorders, August 2011, Wiley

    Carlo Alberto Artusi

  59. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients

    Article • Brain, June 2011, Oxford University Press (OUP)

    Carlo Alberto Artusi